Press Release: ROSEN, THE FIRST FILING FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – RR
NEW YORK, Feb. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026 and 12:00 PM ET on January 29, 2026, both dates inclusive (the “Class Period”), of the important April 3, 2026 lead plaintiff deadline…
Vancouver, BC, Canada, April 17, 2026 (GLOBE NEWSWIRE) -- Global Power Solutions Corp. (TSX Venture Exchange: PWER; Frankfurt Stock Exchanges: NJA) (“Global Power” or the “Company”) is pleased to announce that it has submitted an Expression of Interest (“EOI”) for the potential development and operation of a 15 megawatt (MW) waste-to-energy plant in Kinshasa, Democratic…
HONG KONG, April 17, 2026 (GLOBE NEWSWIRE) -- Felicità Aesthetics today announced the launch of a specialized consultation service designed to address the unique beauty and physiological needs of public figures, with a specific focus on the aerial arts and pole dance communities. Founded by Winry Yip, the initiative aims to professionalize the approach to…
SAN DIEGO, April 16, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Power Solutions International, Inc. (NASDAQ: PSIX) securities between May 8, 2025 and March 2, 2026. Power Solutions designs, manufactures, and sells engines and power systems.
SANTA BARBARA, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Raw Garden®, California’s leading clean cannabis brand, today announced a statewide 4/20 retail partnership offering 25–60% off Raw Garden® products from April 17 through April 20. The limited-time promotion spans hundreds of participating retailers across California, giving consumers broad access to high-quality, single-source cannabis at significant…
PRESS RELEASE New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 Presentations highlight therapy-induced senescence as a new therapeutic opportunity and reinforce the potential of STX-1 as a differentiated approach for solid tumors
